• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名非霍奇金淋巴瘤患者感染新冠病毒后发生鼻眶毛霉菌病

Rhino-Orbital Mucormycosis After COVID-19 Infection in a Patient With Non-Hodgkin's Lymphoma.

作者信息

Hannan Tabiha B, Paul Shrebash, Barai Lovely, Alam Md Rafiqul, Chowdhury Fazle Rabbi

机构信息

Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD.

Microbiology, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) General Hospital, Dhaka, BGD.

出版信息

Cureus. 2022 Feb 22;14(2):e22485. doi: 10.7759/cureus.22485. eCollection 2022 Feb.

DOI:10.7759/cureus.22485
PMID:35345696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8944171/
Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may be succeeded by a spectrum of complications, including invasive fungal infections (IFIs). Here, we describe a case of rhino-orbital mucormycosis in a recovered coronavirus disease-19 (COVID-19) patient with underlying non-Hodgkin's lymphoma (NHL). Our patient was normotensive, non-diabetic, presenting with multiple non-healing ulcers on different parts of the body. She received high-dose glucocorticoids and antibiotics during her severe COVID-19 illness. Three weeks following COVID-19 detection, she developed progressive rhino-orbital lesion with profuse pus formation, along with pain and redness of the left eye. Histopathology from the lesion revealed mucormycosis. She was treated with Amphotericin B. Unfortunately, the patient died after the first cycle of chemotherapy for NHL. Due to the high chance of mortality, timely clinical suspicion along with microbiological diagnosis is necessary for the early detection of infection. Strong policymaking should also be implicated to revisit the cost effectiveness of available treatments to reduce case fatality.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)可能会引发一系列并发症,包括侵袭性真菌感染(IFI)。在此,我们描述了一例康复的冠状病毒病19(COVID-19)患者并发鼻眶毛霉菌病的病例,该患者患有非霍奇金淋巴瘤(NHL)。我们的患者血压正常,无糖尿病史,身体不同部位出现多处不愈合溃疡。在她患重症COVID-19期间接受了大剂量糖皮质激素和抗生素治疗。COVID-19检测三周后,她出现进行性鼻眶病变,伴有大量脓液形成,同时左眼疼痛、发红。病变组织病理学检查显示为毛霉菌病。她接受了两性霉素B治疗。不幸的是,该患者在接受NHL第一轮化疗后死亡。鉴于死亡率较高,及时的临床怀疑以及微生物学诊断对于早期发现感染至关重要。还应制定强有力的政策,重新审视现有治疗方法的成本效益,以降低病死率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/fa958e8c599a/cureus-0014-00000022485-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/1159e2bf7ef2/cureus-0014-00000022485-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/ae2d42d2cda6/cureus-0014-00000022485-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/fa958e8c599a/cureus-0014-00000022485-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/1159e2bf7ef2/cureus-0014-00000022485-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/ae2d42d2cda6/cureus-0014-00000022485-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e70a/8944171/fa958e8c599a/cureus-0014-00000022485-i03.jpg

相似文献

1
Rhino-Orbital Mucormycosis After COVID-19 Infection in a Patient With Non-Hodgkin's Lymphoma.一名非霍奇金淋巴瘤患者感染新冠病毒后发生鼻眶毛霉菌病
Cureus. 2022 Feb 22;14(2):e22485. doi: 10.7759/cureus.22485. eCollection 2022 Feb.
2
Acute Kidney Injury Following Posaconazole for Mucormycosis: SARS-CoV-2 as a Back-Seat Driver.泊沙康唑治疗毛霉菌病后发生急性肾损伤:新型冠状病毒作为幕后推手
Cureus. 2022 Jul 19;14(7):e27018. doi: 10.7759/cureus.27018. eCollection 2022 Jul.
3
Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.鼻眶脑型毛霉菌病:我们在一家三级护理中心的临床特征和治疗方面的经验。
Rom J Ophthalmol. 2021 Oct-Dec;65(4):339-353. doi: 10.22336/rjo.2021.69.
4
Co-occurrence of rhino-orbital mucormycosis and acute lymphoblastic leukemia post-COVID-19 infection in a young adolescent male: A case report from a low middle-income country.一名年轻男性青少年新冠病毒感染后并发鼻眶毛霉菌病和急性淋巴细胞白血病:来自一个低收入中等收入国家的病例报告
Clin Case Rep. 2024 May 23;12(6):e8972. doi: 10.1002/ccr3.8972. eCollection 2024 Jun.
5
Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.不同临床表现的重症 COVID-19 患者对鼻眶脑毛霉菌真菌感染的易感性。
Jpn J Ophthalmol. 2021 Jul;65(4):515-525. doi: 10.1007/s10384-021-00845-5. Epub 2021 May 31.
6
Rhino-Orbital Mucormycosis After COVID-19 Recovery: A Case Report.新冠康复后发生的鼻眶毛霉菌病:一例报告
Int Med Case Rep J. 2022 Oct 14;15:579-586. doi: 10.2147/IMCRJ.S379078. eCollection 2022.
7
Rhino-Orbital Mucormycosis in a COVID-19 Patient: A Dreadful Challenge.一名新冠肺炎患者的鼻眶毛霉菌病:一项严峻挑战。
Kathmandu Univ Med J (KUMJ). 2022 Apr-Jun;20(78):249-251.
8
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature.COVID-19 合并鼻-眶-脑毛霉菌病伴神经血管血栓形成:病例报告及文献复习。
J Neurovirol. 2021 Aug;27(4):644-649. doi: 10.1007/s13365-021-00996-8. Epub 2021 Aug 3.
9
Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report.埃塞俄比亚一名患有新冠肺炎的年轻糖尿病患者的鼻眶脑毛霉菌病:病例报告
Int Med Case Rep J. 2022 May 19;15:251-257. doi: 10.2147/IMCRJ.S364591. eCollection 2022.
10
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.经静脉套管行眶后注射两性霉素 B 治疗 COVID-19 后鼻-眶-脑毛霉菌病。
Indian J Ophthalmol. 2022 Jan;70(1):302-305. doi: 10.4103/ijo.IJO_1511_21.

引用本文的文献

1
Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review.1例COVID-19感染后非糖尿病患者的鼻-眶-脑毛霉菌病:病例报告及文献复习
Cureus. 2022 Dec 23;14(12):e32884. doi: 10.7759/cureus.32884. eCollection 2022 Dec.

本文引用的文献

1
Risk factors for Coronavirus disease-associated mucormycosis.冠状病毒病相关毛霉菌病的危险因素。
J Infect. 2022 Mar;84(3):383-390. doi: 10.1016/j.jinf.2021.12.039. Epub 2021 Dec 30.
2
COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.COVID-19 相关毛霉病:大流行第二波期间印度新兴感染负担的循证批判性综述。
PLoS Negl Trop Dis. 2021 Nov 18;15(11):e0009921. doi: 10.1371/journal.pntd.0009921. eCollection 2021 Nov.
3
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
与 COVID-19 大流行期间毛霉菌病流行相关的危险因素。
Int J Infect Dis. 2021 Oct;111:267-270. doi: 10.1016/j.ijid.2021.08.037. Epub 2021 Aug 24.
4
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.COVID-19 相关毛霉菌病的流行病学和发病机制:印度与世界其他地区。
Mycopathologia. 2021 Dec;186(6):739-754. doi: 10.1007/s11046-021-00584-8. Epub 2021 Aug 19.
5
Risk Factors for Fungal Co-Infections in Critically Ill COVID-19 Patients, with a Focus on Immunosuppressants.危重症COVID-19患者合并真菌感染的危险因素,重点关注免疫抑制剂。
J Fungi (Basel). 2021 Jul 9;7(7):545. doi: 10.3390/jof7070545.
6
Mucormycosis: An opportunistic pathogen during COVID-19.毛霉菌病:COVID-19 期间的机会性病原体。
Environ Res. 2021 Oct;201:111643. doi: 10.1016/j.envres.2021.111643. Epub 2021 Jul 6.
7
COVID-19-associated mucormycosis: An updated systematic review of literature.COVID-19 相关毛霉病:文献的更新系统评价。
Mycoses. 2021 Dec;64(12):1452-1459. doi: 10.1111/myc.13338. Epub 2021 Jun 25.
8
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
9
Fungal co-infection in COVID-19 patients: Should we be concerned?新冠病毒感染患者中的真菌合并感染:我们应予以关注吗?
Rev Iberoam Micol. 2020 Apr-Jun;37(2):41-46. doi: 10.1016/j.riam.2020.07.001. Epub 2020 Sep 14.
10
Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China.真菌合并感染与全球 COVID-19 大流行相关:来自中国的临床和诊断视角。
Mycopathologia. 2020 Aug;185(4):599-606. doi: 10.1007/s11046-020-00462-9. Epub 2020 Jul 31.